Risk factors for late pulmonary homograft stenosis after the Ross procedure  Ehud Raanani, MD, Terrence M Yau, MD, Tirone E David, MD, Goran Dellgren,

Slides:



Advertisements
Similar presentations
Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Advertisements

Postoperative Left Ventricular Mass Regression After Aortic Valve Replacement for Aortic Stenosis  Hiroshi Tomoeda, MD, Tomohiro Ueda, MD, Hideki Teshima,
Ten-year trends in heart valve replacement operations
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy  Svetlana Kotova, MD, Mansen Wang, PhD, Katie.
Intraoperative Pulmonary Artery Stenting: An Alternative Technique for the Management of Pulmonary Artery Stenosis  Fotios A. Mitropoulos, MD, PhD, Hillel.
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Second Chance for a Totally Thoracoscopic Video-Assisted Pulmonary Vein Isolation for Atrial Fibrillation  Antoine H.G. Driessen, MD, Sébastien P.J. Krul,
Ian Adatia, FRCP(C), Andrew M. Atz, MD, Richard A. Jonas, MD, David L
Stentless Porcine Bioprosthesis in Pulmonary Position After Ross Procedure: Midterm Results  Francis Juthier, MD, PhD, André Vincentelli, MD, PhD, Ilir.
CTSNet: a unique educational vehicle
The Ross II Procedure: Pulmonary Autograft in the Mitral Position
Influence of perioperative factors on outcomes in children younger than 18 months after repair of tetralogy of Fallot  Umesh Dyamenahalli, MD, Brian W.
Michael Frenken, MD, Arno Krian, MD  The Annals of Thoracic Surgery 
Lung transplantation for primary and secondary pulmonary hypertension
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.
Ten-year trends in heart valve replacement operations
What is the marginal cost for marginal risk in cardiac surgery?
Pseudoaneurysm of an Aortic Homograft
Endoscopic Saphenous Vein Harvesting
Postoperative Left Ventricular Mass Regression After Aortic Valve Replacement for Aortic Stenosis  Hiroshi Tomoeda, MD, Tomohiro Ueda, MD, Hideki Teshima,
Brian C. Gulack, MD, Ehsan Benrashid, MD, Robert D. B
Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch  Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,
Severe ischemic early liver injury after cardiac surgery
Transcatheter Aortic Valve Implantation Under Direct Visualization in Homograft Valve Endocarditis  Tarek Chami, MD, Guilherme Attizzani, MD, Benjamin.
Analyzing Effectiveness of Routine Pleural Drainage After Nuss Procedure: A Randomized Study  Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski, MD, PhD, Piotr.
Surgical intervention for complications of transcatheter dilation procedures in congenital heart disease  Doff B McElhinney, MD, V.Mohan Reddy, MD, Phillip.
Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years  Khaled D. Algarni, MD, MHS, Manjula Maganti,
Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery  Sophie Piérard, MD, Christophe.
Early pulmonary resection for localized mycobacterium avium complex disease  Yuji Shiraishi, MD, Kanae Fukushima, MD, Hikotaro Komatsu, MD, Atsuyuki Kurashima,
In situ repair of aortobronchial, aortoesophageal, and aortoenteric fistulae with cryopreserved aortic homografts  Paul R. Vogt, MD, Thomas Pfammatter,
Use of Amiodarone After Major Lung Resection
Are older patients with mechanical heart valves at increased risk?
Abdelsalam M. Elhenawy, MD, PhD, Christopher M
Biventricular repair in neonates with hypoplastic left heart complex
Expandable Valve for Pediatric Application Constructed From Human Venous Valved Conduit Within a Stent  Erin G. Roberts, MS, Luis Quinonez, MD, Breanna.
Traumatic tricuspid valve regurgitation and cerebral emboli
Punch Pulmonary Valvectomy: Another Alternative to Treat Critical Pulmonary Stenosis  Simcha Milo, Yaron Bar-El, Zvi Adler, Michael Halberthal, Abraham.
Serial change in the atrial transport function after the radial incision approach  Yosuke Ishii, MD, Takashi Nitta, MD, Masahiro Fujii, MD, Hidetsugu Ogasawara,
Redo Aortic Valve Replacement in Children
Valve performance classification in 630 subcoronary Ross patients over 22 years  Hans-Hinrich Sievers, MD, Ulrich Stierle, MD, Michael Petersen, MD, Stefan.
Repair of an aneurysm of the pulmonary trunk in a 65-year-old patient
Annelies E. van der Hulst, MD, PhD, Marije G. Hylkema, BS, Hubert W
Roni M. Jacobsen, MD, Michael G. Earing, MD, Garick D
Hemodynamics and early clinical performance of the St
The Ross procedure: Outcomes at 20 years
Brian M. Cardis, MD, Derek A. Fyfe, MD, PhD, William T. Mahle, MD 
An Increased Incidence of Conduit Endocarditis in Patients Receiving Bovine Jugular Vein Grafts Compared to Cryopreserved Homograft for Right Ventricular.
Role of transvalvular gradient in outcome from valve replacement for aortic stenosis  Arjuna Weerasinghe, FRCS, PhD, Merangani Yusuf, FRCS, Thanos Athanasiou,
Is there a role for pneumonectomy in pulmonary metastases?1
Very Prolonged Stay in the Intensive Care Unit After Cardiac Operations: Early Results and Late Survival  Shuli Silberman, MD, Daniel Bitran, MD, Daniel.
Anthony P.C Yim, MD, Song Wan, MD, PhD, Tak Wai Lee, Ahmed A Arifi 
The Ross operation in a Jehovah’s Witness: a paradigm for heart surgery in children without transfusion  Kagami Miyaji, MD, Robert L Hannan, MD, Jorge.
Richard S. D'Agostino, Lars G. Svensson, Deborah J. Neumann, Husam H
Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction  David A. Cotoni, DO, Robert T. Palac, MD,
K. Eric Sommers, MD, Bartley P. Griffith, MD, Robert L
Multiple Valve Surgery with Beating Heart Technique
Reversibility of Cardiac Dysfunction After Valve Replacement in Elderly Patients With Severe Aortic Stenosis  Masafumi Natsuaki, MD, Tsuyoshi Itoh, MD,
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD 
The use of routine chest x-ray films after chest tube removal in postoperative cardiac patients  James T McCormick, DO, Michael S O’Mara, MD, Pavlos K.
Thomas G. Gleason, MD, Tirone E. David, MD, Joseph S
Pulmonary artery banding before Norwood procedure
Adnan Cobanoglu, MD, Jess M Schultz, MD  The Annals of Thoracic Surgery 
Endomyocardial Biopsy in the Heterotopic Heart Transplant Patient
Ebstein’s Anomaly of the Tricuspid Valve in Combination of Tetralogy of Fallot: Total Correction in Infancy  Chao-Han Lai, MD, Jing-Ming Wu, MD, Yu-Jen.
Antero-axillary access for hypoplastic aortic arch repair
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure  J.F.Matthias Bechtel, MD, Claus Bartels, MD, Claudia Schmidtke,
Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus  Michael A Borger, MD, PhD, Terrence M Yau, MD, MS, Vivek.
Presentation transcript:

Risk factors for late pulmonary homograft stenosis after the Ross procedure  Ehud Raanani, MD, Terrence M Yau, MD, Tirone E David, MD, Goran Dellgren, MD, Brian D Sonnenberg, MD, Ahmed Omran, MD  The Annals of Thoracic Surgery  Volume 70, Issue 6, Pages 1953-1957 (December 2000) DOI: 10.1016/S0003-4975(00)01905-6

Fig 1 Early and late postoperative gradients across the pulmonary homograft in 105 patients undergoing the Ross procedure. No Doppler gradient across the homograft was noted in any patient 1 week postoperatively, but late peak Doppler gradients were 20 mm Hg or more in 30 of 105 patients (29%) and 40 mm Hg or more in 4 of 105 patients (3.8%). The Annals of Thoracic Surgery 2000 70, 1953-1957DOI: (10.1016/S0003-4975(00)01905-6)

Fig 2 Univariate relationship of risk factors previously associated with increased homograft viability on mean gradients across the pulmonary homograft. Younger donor age (p = 0.002), shorter length of cryopreservation (p = 0.02), and beating heart donor status (p = 0.059) were most significant, but all factors associated with greater viability demonstrated at least a trend toward increased gradients. The Annals of Thoracic Surgery 2000 70, 1953-1957DOI: (10.1016/S0003-4975(00)01905-6)

Fig 3 Effect of risk factors previously associated with increased homograft viability on late pulmonary homograft gradients. These putative risk factors included donor age less than 30 years, ABO mismatch, beating heart donor status, warm ischemic time less than 2 hours, amphotericin usage, and length of cryopreservation less than 20 months. Mean Doppler gradients across the pulmonary homograft increased from 6 ± 4 mm Hg in homografts with none of these risk factors to 26 ± 3 mm Hg in homografts with all six of these risk factors (p = 0.002). The Annals of Thoracic Surgery 2000 70, 1953-1957DOI: (10.1016/S0003-4975(00)01905-6)